Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
11th Apr 202212:19 pmRNSNet Asset Value(s)
8th Apr 202212:06 pmRNSNet Asset Value(s)
7th Apr 202212:37 pmRNSNet Asset Value(s)
7th Apr 202210:18 amRNSMonth End Net Asset Value(s)
6th Apr 202212:48 pmRNSNet Asset Value(s)
5th Apr 20221:00 pmRNSNet Asset Value(s)
4th Apr 20221:36 pmRNSGearing disclosure
4th Apr 202212:44 pmRNSNet Asset Value(s)
31st Mar 202212:20 pmRNSNet Asset Value(s)
30th Mar 202212:30 pmRNSNet Asset Value(s)
29th Mar 20221:08 pmRNSNet Asset Value(s)
28th Mar 20221:01 pmRNSGearing disclosure
28th Mar 202212:20 pmRNSNet Asset Value(s)
25th Mar 20225:45 pmRNSCompliance with Market Abuse Regualtion
25th Mar 202212:03 pmRNSNet Asset Value(s)
24th Mar 202212:31 pmRNSNet Asset Value(s)
23rd Mar 202212:30 pmRNSNet Asset Value(s)
22nd Mar 202212:13 pmRNSNet Asset Value(s)
21st Mar 20222:12 pmRNSGearing Disclosures
21st Mar 20221:01 pmRNSNet Asset Value(s)
18th Mar 202212:29 pmRNSNet Asset Value(s)
17th Mar 202212:45 pmRNSNet Asset Value(s)
16th Mar 20221:10 pmRNSNet Asset Value(s)
15th Mar 20221:25 pmRNSNet Asset Value(s)
14th Mar 20223:44 pmRNSPortfolio disclosure
14th Mar 20221:20 pmRNSGearing disclosure
14th Mar 20221:10 pmRNSNet Asset Value(s)
11th Mar 202212:49 pmRNSNet Asset Value(s)
10th Mar 202212:54 pmRNSNet Asset Value(s)
9th Mar 20221:32 pmRNSNet Asset Value(s)
8th Mar 20221:04 pmRNSNet Asset Value(s)
7th Mar 20225:12 pmRNSGearing disclosure
7th Mar 202212:53 pmRNSNet Asset Value(s)
7th Mar 202210:40 amRNSMonth End Net Asset Value(s)
4th Mar 20226:06 pmRNSNet Asset Value(s)
3rd Mar 202212:52 pmRNSNet Asset Value(s)
2nd Mar 20222:22 pmRNSNet Asset Value(s)
2nd Mar 20221:52 pmRNSQuarterly disclosure
1st Mar 20227:00 amRNSEdison issues review on abrdn Latin American
28th Feb 20223:57 pmRNSGearing disclosure
28th Feb 20221:01 pmRNSNet Asset Value(s)
25th Feb 202212:50 pmRNSNet Asset Value(s)
24th Feb 202212:39 pmRNSNet Asset Value(s)
23rd Feb 202212:58 pmRNSNet Asset Value(s)
22nd Feb 20221:03 pmRNSNet Asset Value(s)
21st Feb 20221:12 pmRNSGearing disclosure
21st Feb 202212:11 pmRNSNet Asset Value(s)
18th Feb 20223:47 pmRNSDirectorate Changes
18th Feb 202211:57 amRNSNet Asset Value(s)
17th Feb 202211:02 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.